These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


202 related items for PubMed ID: 31203405

  • 1. Respiratory motion in children and young adults undergoing liver magnetic resonance imaging with intravenous gadoxetate disodium contrast material.
    Gilligan LA, Trout AT, Anton CG, Schapiro AH, Towbin AJ, Dillman JR.
    Pediatr Radiol; 2019 Aug; 49(9):1171-1176. PubMed ID: 31203405
    [Abstract] [Full Text] [Related]

  • 2. Matched within-patient cohort study of transient arterial phase respiratory motion-related artifact in MR imaging of the liver: gadoxetate disodium versus gadobenate dimeglumine.
    Davenport MS, Caoili EM, Kaza RK, Hussain HK.
    Radiology; 2014 Jul; 272(1):123-31. PubMed ID: 24617733
    [Abstract] [Full Text] [Related]

  • 3. Respiratory motion artifact affecting hepatic arterial phase imaging with gadoxetate disodium: examination recovery with a multiple arterial phase acquisition.
    Pietryga JA, Burke LM, Marin D, Jaffe TA, Bashir MR.
    Radiology; 2014 May; 271(2):426-34. PubMed ID: 24475864
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of acute transient dyspnea after intravenous administration of gadoxetate disodium and gadobenate dimeglumine: effect on arterial phase image quality.
    Davenport MS, Viglianti BL, Al-Hawary MM, Caoili EM, Kaza RK, Liu PS, Maturen KE, Chenevert TL, Hussain HK.
    Radiology; 2013 Feb; 266(2):452-61. PubMed ID: 23192781
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. CAIPIRINHA-Dixon-TWIST (CDT)-VIBE MR imaging of the liver at 3.0T with gadoxetate disodium: a solution for transient arterial-phase respiratory motion-related artifacts?
    Gruber L, Rainer V, Plaikner M, Kremser C, Jaschke W, Henninger B.
    Eur Radiol; 2018 May; 28(5):2013-2021. PubMed ID: 29264636
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Transient respiratory motion artifact during arterial phase MRI with gadoxetate disodium: risk factor analyses.
    Kim SY, Park SH, Wu EH, Wang ZJ, Hope TA, Chang WC, Yeh BM.
    AJR Am J Roentgenol; 2015 Jun; 204(6):1220-7. PubMed ID: 26001231
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Gadoxetate disodium-related event during image acquisition: a prospective multi-institutional study for better MR practice.
    Kromrey ML, Hori M, Goshima S, Kozaka K, Hyodo T, Nakamura Y, Nishie A, Tamada T, Shimizu T, Kanki A, Motosugi U.
    Eur Radiol; 2020 Jan; 30(1):281-290. PubMed ID: 31338655
    [Abstract] [Full Text] [Related]

  • 12. Transient Severe Motion Artifact Related to Gadoxetate Disodium-Enhanced Liver MRI: Frequency and Risk Evaluation at a German Institution.
    Well L, Rausch VH, Adam G, Henes FO, Bannas P.
    Rofo; 2017 Jul; 189(7):651-660. PubMed ID: 28445909
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of incidence of acute transient dyspnea and related artifacts after administration of gadoxetate disodium: a prospective observational study.
    Grazioli L, Faletti R, Frittoli B, Battisti G, Ambrosini R, Romanini L, Gatti M, Fonio P.
    Radiol Med; 2018 Dec; 123(12):910-917. PubMed ID: 30084108
    [Abstract] [Full Text] [Related]

  • 14. Effect of Gadoxetate Disodium on Arterial Phase Respiratory Waveforms Using a Quantitative Fast Fourier Transformation-Based Analysis.
    Davenport MS, Malyarenko DI, Pang Y, Hussain HK, Chenevert TL.
    AJR Am J Roentgenol; 2017 Feb; 208(2):328-336. PubMed ID: 27929673
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Intravenous Gadoxetate Disodium Administration Reduces Breath-holding Capacity in the Hepatic Arterial Phase: A Multi-Center Randomized Placebo-controlled Trial.
    McClellan TR, Motosugi U, Middleton MS, Allen BC, Jaffe TA, Miller CM, Reeder SB, Sirlin CB, Bashir MR.
    Radiology; 2017 Feb; 282(2):361-368. PubMed ID: 27509544
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Respiratory-motion artefacts in liver MRI following injection of gadoxetate disodium and gadobenate dimeglumine: an intra-individual comparative study in cirrhotic patients.
    Furlan A, Close ON, Borhani AA, Wu YH, Heller MT.
    Clin Radiol; 2017 Jan; 72(1):93.e1-93.e6. PubMed ID: 27633725
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Transient severe motion in the arterial phase during gadoxetate disodium-enhanced MR imaging: evaluation of patients with multiple MR examinations.
    Im WH, Song JS, Park EH, Kwak HS.
    Abdom Radiol (NY); 2017 Oct; 42(10):2393-2401. PubMed ID: 28396919
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.